Christopher J. Earley, MB, BCh, PhD Professor Department of Neurology Johns Hopkins School of Medicine

Size: px
Start display at page:

Download "Christopher J. Earley, MB, BCh, PhD Professor Department of Neurology Johns Hopkins School of Medicine"

Transcription

1 Christopher J. Earley, MB, BCh, PhD Professor Department of Neurology Johns Hopkins School of Medicine

2 1. Medication working well but do you still need it? 2. Medication working well but do you really want to be on it? 3. You are having problems with the current medication

3 1. Family history study indicates significant symptom variability over time 2. Potential triggers or aggravants may be reduced or eliminated Iron deficiency (6 weeks) Poor sleep (e.g., sleep apnea) Pain conditions (e.g., knee replacement) Medications (e.g., antidepressants) Pregnancy

4 1. RLS x 22 years 2. Gabapentin; no SX on TX 3. Current dose 1800mg at night 4. Ferritin 117 ug/l 5. Unable to refill RX on time 6. 6 days drug free occasional, minimal SX ; hydrocodone prn

5 1. RLS x 12 years 2. Requip then Mirapex (0.75 mg) 3. RLS throughout day; hypersomnia 4. Ferritin 154 ug/l 5. Venlafaxin 150 mg x 12 years 6. Off Mirapex 11 day nightly RLS 7. Off Venlafaxin 5 days no SX

6 1. RLS x 6 years; blood donor/nsaid 2. Pramipexole (0.5 mg) 6 year 3. Ferritin 35 ug/l mg (IV) iron 5. 6-weeks post iron infusion then tapered off pramipexole days drug free no SX

7 This is not about need as you may still have RLS when you get off the drug. The question is, do I want to be on this drug every day for the rest of my life?

8 1. RLS x 55 years 2. Bedside bicycle for 40 years 3. Enticed by advertising; Mirapex 0.5 mg x 8 year 4. Medication working alright but did not want to take medication anymore 5. Tapered off days drug free baseline: nightly bedtime RLS. Return to bedside bicycle

9 The usual problems are : 1. Side effects 2. Tolerance (opiates and Alpha-2 delta) 3. Augmentation (Dopamine agents) 4. Occasionally, financial

10 1. RLS x 15 years 2. Methadone 10 mg x 5 year 3. C/O daytime sleepiness 4. Ferritin 110 ug/l 5. Tapered off days drug free evening RLS, so returned to methadone 7.5 mg BUT now no sleepiness

11 1. RLS x 30 years 2. DA agonist for 15 yrs; direct conversion to oxycodone ER 3. Currently oxycodone ER 40 mg TID 4. Ferritin 210 ug/l 5. Tapered off oxycodone days drug free restarted oxycodone ER 10mg PM and 20 mg qhs

12 1. RLS x 37 years 2. Requip for 12 year; augmented 3. Current dose 4 mg 4. Ferritin Tapered off days drug free mild, bedtime SX 4/7 nights - no further meds

13

14 1. Down regulation of DA receptor 2. Imbalance in the DA receptor Type D1-D 2 Pre vs post D2/3/5 or D1/5 3. Alterations of DAR interaction 4. Feedback inhibition of dopamine synthesis

15 Normal Conditions Decreasing DA Activity (augmentation and tolerance) RLS Pre-treatment Symptomatic period RLS Post-treatment Diurnal Changes in Dopaminergic Activity Earlier onset RLS Symptom Threshold NIGHT DAY

16 Is a result of chronic use of dopamine drugs Which results in decrease in the brain s natural dopamine levels AND A increase in dependency on the dopamine drug

17 Reducing DA drug Þ insufficient brain DA Þ increased production of DA Reducing DA drug Þ insufficient brain DA Þ rebound of RLS Increased DA production Þ improvement in RLS

18 Start with earliest scheduled dose Incremental Reduction 0.25 mg Pramipexole 0.5 mg ropinirole 1 mg rotigotine Rate of reduction Every 3-5 days minimum

19 From tapering to drug free Days 1-2: RLS severe; NO sleep Days 3-4: RLS severe, 1-2 Hrs total sleep; sleepiness, depression, anxiety Days 5-7: 2-4 hrs sleep; symptoms continue to role back; less intense Days 10-14: 4-6 hrs sleep; evening bedtime Sx; baseline?

20 Symptoms may continue to improve 3-6 months Living drug-free with RLS is a personal decision Once augmented; always augmented Return to prior drug if not DA agent Try an alternative treatment

21 Available to Foundation Members at

22

23

24

AUGMENTATION SUFFERING AND WHAT CAN BE DONE ABOUT IT. John W. Winkelman MD PhD Massachusetts General Hospital Harvard Medical School Boston, MA

AUGMENTATION SUFFERING AND WHAT CAN BE DONE ABOUT IT. John W. Winkelman MD PhD Massachusetts General Hospital Harvard Medical School Boston, MA AUGMENTATION SUFFERING AND WHAT CAN BE DONE ABOUT IT John W. Winkelman MD PhD Massachusetts General Hospital Harvard Medical School Boston, MA Disclosure Information Type of Affiliation Commercial Entity

More information

The Prevention & Treatment of Augmentation

The Prevention & Treatment of Augmentation The Prevention & Treatment of Augmentation MARK J BUCHFUHRER, MD S T A N F O R D U N I VERSITY S L E E P M E D I C IN E C E N T ER, R E D W O O D C I T Y, C A P R I VATE P R ACTICE, D O W N E Y, C A 2017

More information

Case 1. A. Insomnia B. Restless leg syndrome C. Peripheral neuropathy D. Osteoarthritis of the hip. Disclosures. Diagnosis for trouble falling asleep

Case 1. A. Insomnia B. Restless leg syndrome C. Peripheral neuropathy D. Osteoarthritis of the hip. Disclosures. Diagnosis for trouble falling asleep Disclosures I have no disclosures Case 1 Liza Ashbrook, MD Assistant Clinical Professor UCSF Department of Neurology History of Present Illness Diagnosis for trouble falling asleep 70-year-man with obstructive

More information

Basics of Restless Legs Syndrome (Willis-Ekbom Disease)

Basics of Restless Legs Syndrome (Willis-Ekbom Disease) Basics of Restless Legs Syndrome (Willis-Ekbom Disease) Michael H. Silber, M.B.Ch.B. Professor of Neurology Mayo Clinic College of Medicine Objectives Understand how RLS is diagnosed Understand what we

More information

What is Augmentation? How to diagnose? What to do?

What is Augmentation? How to diagnose? What to do? What is Augmentation? How to diagnose? What to do? Diego Garcia-Borreguero Madrid, SPAIN Dopaminergics do work: The case of L-dopa 100 80.005.031.002.025 ns ns p-values PLM/h 60 40 Placebo L-Dopa 20 0

More information

The Management of Restless Legs Syndrome in Adults in Primary Care Version 1.1 February 2019

The Management of Restless Legs Syndrome in Adults in Primary Care Version 1.1 February 2019 The Management of Restless Legs Syndrome in Adults in Primary Care Version 1.1 February 2019 VERSION CONTROL Version Number Date Amendments made 1.0 December 2015 1.1 February 2019 Version 1. Approved

More information

Depression and RLS. John W. Winkelman MD, PhD Departments of Psychiatry and Neurology Massachusetts General Hospital

Depression and RLS. John W. Winkelman MD, PhD Departments of Psychiatry and Neurology Massachusetts General Hospital Depression and RLS John W. Winkelman MD, PhD Departments of Psychiatry and Neurology Massachusetts General Hospital Associate Professor of Psychiatry Harvard Medical School A 42 year old man has a three

More information

Restless Legs Syndrome. Brian Koo, M.D. University Hospitals

Restless Legs Syndrome. Brian Koo, M.D. University Hospitals Restless Legs Syndrome Brian Koo, M.D. University Hospitals Outline of Talk Diagnosis/classification Symptomatology Evaluation PLMS Epidemiology Prevalence Risk factor Effect of Quality of Life Pathophysiology

More information

UPDATE: DIAGNOSIS & MANAGEMENT OF RLS

UPDATE: DIAGNOSIS & MANAGEMENT OF RLS UPDATE: DIAGNOSIS & MANAGEMENT OF RLS Beenish K. Khwaja, D.O. Legacy Medical Group--Neurology & Sleep Medicine Director, Legacy Mt. Hood Sleep Center Outline Definition & Diagnostic Criteria Epidemiology

More information

Options for Treating Restless Legs Syndrome. A Review of the Research for Adults

Options for Treating Restless Legs Syndrome. A Review of the Research for Adults Options for Treating Restless Legs Syndrome A Review of the Research for Adults Is This Information Right for Me? Yes, this information is for you if: Your doctor* has told you that you have restless legs

More information

R E S T L E S S L E G S S Y N D R O M E. Causes, diagnosis and treatment. For the patient living with restless legs syndrome (RLS)

R E S T L E S S L E G S S Y N D R O M E. Causes, diagnosis and treatment. For the patient living with restless legs syndrome (RLS) R E S T L E S S L E G S S Y N D R O M E Causes, diagnosis and treatment For the patient living with restless legs syndrome (RLS) www.rls.org RESTLESS LEGS SYNDROME Restless legs syndrome (RLS), also called

More information

Best Medical Treatments for Parkinson s disease

Best Medical Treatments for Parkinson s disease Best Medical Treatments for Parkinson s disease Bernadette Schöneburg, M.D. June 20 th, 2015 What is Parkinson s Disease (PD)? Progressive neurologic disorder that results from the loss of specific cells

More information

Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group..

Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group.. Restless Legs Syndrome: Impact, Recognition, and Management Pierre Bou-Khalil Khalil, MD, FCCP, D ABSM What is RLS and what is its impact? Definition of RLS RLS is characterized by disagreeable leg sensations

More information

Restless Legs Syndrome: What is Ferritin & Why Do We Want To Be Iron Man or Iron Woman

Restless Legs Syndrome: What is Ferritin & Why Do We Want To Be Iron Man or Iron Woman Restless Legs Syndrome: What is Ferritin & Why Do We Want To Be Iron Man or Iron Woman Focus Fall 2017 Conference Poughkeepsie, NY Dr. Steven A Thau MD Director, Pulmonary and Sleep Medicine Phelps Memorial

More information

Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.

Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O. Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O. Parkinson s Epidemiology AFFECTS 1% OF POPULATION OVER 65 MEAN AGE OF ONSET 65 MEN:WOMEN 1.5:1 IDIOPATHIC:HEREDITARY 90:10

More information

Where do you get most of your information about medications?

Where do you get most of your information about medications? DRUG ACTION AND RLS Jacquelyn Bainbridge, Pharm.D., FCCP Professor Pei Shieen Wong, Pharm.D., BCPS University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences,

More information

Can valium help restless leg syndrome

Can valium help restless leg syndrome Can valium help restless leg syndrome The Borg System is 100 % Can valium help restless leg syndrome Mar 1, 2012. Fortunately, certain lifestyle strategies can help you manage milder forms of RLS, and

More information

SLEEP UPDATE 2008 SLEEP HYPNOGRAM. David Claman, MD UCSF Sleep Disorders Center

SLEEP UPDATE 2008 SLEEP HYPNOGRAM. David Claman, MD UCSF Sleep Disorders Center SLEEP UPDATE 2008 SLEEP HYPNOGRAM David Claman, MD UCSF Sleep Disorders Center Insomnia Case A 40 year old man c/o insomnia at sleep onset. He worries about sleep at night, and takes 2-3 hrs to fall asleep.

More information

Sleep and a Healthy Heart

Sleep and a Healthy Heart Sleep and a Healthy Heart Dr. R. John Kimoff, MD, FRCP(C) Professor of Medicine, Respiratory Division Director, Sleep Laboratory, MCI-McGill University Health Centre Montréal, Québec, Canada Women s Healthy

More information

Learning Objectives. Sleep and Sleep Disorders NOT called Sleep Apnea. Socioeconomic Consequences. Socioeconomic Consequences

Learning Objectives. Sleep and Sleep Disorders NOT called Sleep Apnea. Socioeconomic Consequences. Socioeconomic Consequences Sleep and Sleep Disorders NOT called Sleep Apnea Jerrold Kram, MD, FCCP, FAASM Medical Director, California Center for Sleep Disorders Board of Directors, National Sleep Foundation Learning Objectives

More information

Restless Legs Syndrome

Restless Legs Syndrome Parkinson's Disease Center and Movement Disorders Clinic 7200 Cambridge Street, 9th Floor, Suite 9A Houston, Texas 77030 713-798-2273 phone www.jankovic.org Restless Legs Syndrome Diagnosis With the emergence

More information

Sleep Disorders: Assessment and Therapeutic Options

Sleep Disorders: Assessment and Therapeutic Options Sleep Disorders: Assessment and Therapeutic Options John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor

More information

Dr Alex Bartle. Medical Director Sleep Well Clinic Christchurch

Dr Alex Bartle. Medical Director Sleep Well Clinic Christchurch Dr Alex Bartle Medical Director Sleep Well Clinic Christchurch 8:30-9:25 WS #191: Sleep Disorders in The Elderly 9:35-10:30 WS #203: Sleep Disorders in The Elderly (Repeated) REM - Rapid Eye Movement

More information

Restless Legs Syndrome: Is This a Pain Issue?

Restless Legs Syndrome: Is This a Pain Issue? Restless Legs Syndrome: Is This a Pain Issue? Kathy Lattavo, RN, MSN, ACNS- BC, RN-BC Objectives Describe the pathophysiology of RLS. Evaluate treatment for RLS. Compare & contrast RLS & pain. Definitions

More information

Disclosures. Speaker: Teva, UCB, Purdue Advisory Board: Welltrinsic Sleep Network Consultant: Vapotherm, Inc. National Interpretor: Novasom

Disclosures. Speaker: Teva, UCB, Purdue Advisory Board: Welltrinsic Sleep Network Consultant: Vapotherm, Inc. National Interpretor: Novasom So PAP Doesn t Work Rochelle Goldberg, MD, FAASM, FCCP Diplomat, American Board of Sleep Medicine Director Sleep Medicine Services Main Line Health Systems Lankenau Medical Center and Paoli Hospital Disclosures

More information

DESCRIPTION.

DESCRIPTION. Tapering off requip May 29, 2015. We conclude that for augmentation in RLS, gradual tapering of the there were four patients taking regular or extended length ropinirole with a mean. Of the 7 patients

More information

Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation

Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation CNS Drugs (2015) 29:351 357 DOI 10.1007/s40263-015-0250-2 CURRENT OPINION Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation

More information

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Actigraphy, 475, 485, 496 Adolescents, sleep disorders in, 576 578 Adults, sleep disorders in, 578 580 Advanced sleep phase disorder, 482 Age,

More information

Sleep and Traumatic Brain Injury (TBI)

Sleep and Traumatic Brain Injury (TBI) Sleep and Traumatic Brain Injury (TBI) A resource for individuals with traumatic brain injury and their supporters This presentation is based on TBI Model Systems research and was developed with support

More information

Weaning off requip. Cari untuk: Cari Cari

Weaning off requip. Cari untuk: Cari Cari Cari untuk: Cari Cari Weaning off requip Weaning Off Mirapex. Readers have updated us on their weaning efforts. Mirapex has. I do not want to replace this med with Requip,. The pramipexole is the same

More information

Steven Prakken MD Chief, Medical Pain Service Duke Pain Medicine

Steven Prakken MD Chief, Medical Pain Service Duke Pain Medicine Steven Prakken MD Chief, Medical Pain Service Duke Pain Medicine International Association for the Study of Pain "Pain is an unpleasant sensory and emotional experience associated with actual or potential

More information

Medications used to treat Parkinson s disease

Medications used to treat Parkinson s disease Medications used to treat Parkinson s disease Edwin B. George, M.D., Ph.D. Director of Wayne State University Movement Disorder Clinic University Health Center Neurology Clinic University Health The John

More information

Restless Leg Syndrome What does it mean to you in the middle of the night?

Restless Leg Syndrome What does it mean to you in the middle of the night? S Restless Leg Syndrome What does it mean to you in the middle of the night? David A. Weed, DO, FCCP, D, ABSM Sleep Disorders Center ~ The Aroostook Medical Center Presque Isle, Maine S 1990 S 22 year

More information

APPENDIX E: HEALTHCARE PRACTITIONER- REPORTED REDUCTION OF PAIN MEDICATION

APPENDIX E: HEALTHCARE PRACTITIONER- REPORTED REDUCTION OF PAIN MEDICATION Contents Appendix E: Healthcare Practitioner-Reported Reduction of Pain Medication... E-1 Appendix E: Healthcare Practitioner- Reported Reduction of Pain Medication Note: Word choice and spellings have

More information

Optimizing Clinical Communication in Parkinson s Disease:

Optimizing Clinical Communication in Parkinson s Disease: Optimizing Clinical Communication in Parkinson s Disease:,Strategies for improving communication between you and your neurologist PFNCA Symposium March 25, 2017 Pritha Ghosh, MD Assistant Professor of

More information

Depression & Anxiety. What can I do? What are other possible treatments? What is this? Why does this happen? KEY POINTS

Depression & Anxiety. What can I do? What are other possible treatments? What is this? Why does this happen? KEY POINTS Depression & Anxiety One set of important protectors from depression is friends and family as much as you can, keep yourself active and engaged with others. Exercise, particularly while outside, may help.

More information

10th Medicine Review Course st July Prakash Kumar

10th Medicine Review Course st July Prakash Kumar 10th Medicine Review Course 2018 21 st July 2018 Drug Therapy for Parkinson's disease Prakash Kumar National Neuroscience Institute Singapore General Hospital Sengkang General Hospital Singhealth Duke-NUS

More information

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits Overview Overview Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits The differential diagnosis of Parkinson s disease Primary vs. Secondary Parkinsonism Proteinopathies:

More information

Treatment of sleep disorders in

Treatment of sleep disorders in Treatment of sleep disorders in Parkinson s s disease (PD) K. Ray Chaudhuri London, UK GPSRC CNS 176 0709 RTG 1 Managing insomnia in PD Onset/initiation Adjustment of anti-pd treatment Sleep hygiene Hypnotics

More information

How Much Sleep Do We Need? 10/5/2015. Insomnia Is Not An Ambien Deficiency Disease. I Can t Sleep. 10 Essential Questions

How Much Sleep Do We Need? 10/5/2015. Insomnia Is Not An Ambien Deficiency Disease. I Can t Sleep. 10 Essential Questions Insomnia Is Not An Ambien Deficiency Disease 10 Essential Questions Janet E. Tatman, PhD, PA-C Fellow American Academy of Sleep Medicine Certified in Behavioral Sleep Medicine I Can t Sleep Chronic = 10%

More information

Motor Fluctuations Stephen Grill, MD, PHD Parkinson s and Movement Disorders Center of Maryland and Johns Hopkins University

Motor Fluctuations Stephen Grill, MD, PHD Parkinson s and Movement Disorders Center of Maryland and Johns Hopkins University Motor Fluctuations Stephen Grill, MD, PHD Parkinson s and Movement Disorders Center of Maryland and Johns Hopkins University I have no financial interest with any entity producing marketing, re-selling,

More information

Sleep - Definition. Slide 1 Sleep & Developmental Disabilities: Lessons for All Children. Slide 2 Importance of Sleep. Slide 3. Lawrence W.

Sleep - Definition. Slide 1 Sleep & Developmental Disabilities: Lessons for All Children. Slide 2 Importance of Sleep. Slide 3. Lawrence W. 1 Sleep & Developmental Disabilities: Lessons for All Children March 28, 2012 Lawrence W. Brown, MD Pediatric Neuropsychiatry Program Sleep Disorders Center The Children s Hospital of Philadelphia 2 Importance

More information

RESTLESS LEGS SYNDROME IN CHILDREN AND ADOLESCENTS

RESTLESS LEGS SYNDROME IN CHILDREN AND ADOLESCENTS RESTLESS LEGS SYNDROME IN CHILDREN AND ADOLESCENTS Tracy Carbone, MD Medical Director of Sleep Medicine Lee Health Golisano Children s Hospital of Southwest Florida Fort Myers, FL OVERVIEW Although the

More information

Author: Colleen Symanski-Sanders, RN, Forensic Nurse Specialist. Objectives: Upon completion of this CNE article, the reader will be able to

Author: Colleen Symanski-Sanders, RN, Forensic Nurse Specialist. Objectives: Upon completion of this CNE article, the reader will be able to Restless Leg Syndrome Expires Wednesday, October 31, 2018 Nursing Colleen Symanski-Sanders, RN Objectives 1. Describe the three different categories of restless legs syndrome. 2. Explain the main symptoms

More information

Psychopharmacology of Sleep Disorders

Psychopharmacology of Sleep Disorders Psychopharmacology of Sleep Disorders John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor of Psychiatry

More information

RESTLESS LEGS SYNDROME AMONG THE ELDERLY

RESTLESS LEGS SYNDROME AMONG THE ELDERLY REVIEW ARTICLE RESTLESS LEGS SYNDROME AMONG THE ELDERLY Pei-Hao Chen 1,2, Shih-Jung Cheng 1,2 * 1 Department of Neurology, Mackay Memorial Hospital, and 2 Mackay Medicine, Nursing and Management College,

More information

OBJECTIVES. The psychiatric, medical, and neurologic causes of sleep problems. Office-based and objective methods of evaluating sleep

OBJECTIVES. The psychiatric, medical, and neurologic causes of sleep problems. Office-based and objective methods of evaluating sleep SLEEP ISSUES 1 OBJECTIVES 2 Know and understand: Age-related changes in sleep The psychiatric, medical, and neurologic causes of sleep problems Office-based and objective methods of evaluating sleep Appropriate

More information

14. Percent Mellinger GD et al. Arch Gen Psychiatry. 1985;42: ICSD III

14. Percent Mellinger GD et al. Arch Gen Psychiatry. 1985;42: ICSD III 4:45 5:45 pm Management of Insomnia and Other Disorders Presenter Disclosure Information The following relationships exist related to this presentation: Alon Y. Avidan, MD, MPH, FAAN, FAASM: Speakers Bureau

More information

PD ExpertBriefing: What s in the Parkinson s Pipeline

PD ExpertBriefing: What s in the Parkinson s Pipeline PD ExpertBriefing: What s in the Parkinson s Pipeline Presented by: David G. Standaert, M.D., Ph.D. Professor of Neurology Director, Center for Neurodegeneration and Experimental Therapeutics University

More information

10 mg hydrocodone equals how much oxycodone

10 mg hydrocodone equals how much oxycodone Cari untuk: Cari Cari 10 mg hydrocodone equals how much oxycodone Posts about dilaudid 8 vs oxycodone 30 written by buyprescriptionmedication. Can you help me with the conversion of Oxycodone IR (5mg tab)

More information

Evaluation and Management of Parkinson s Disease in the Older Patient

Evaluation and Management of Parkinson s Disease in the Older Patient Evaluation and Management of Parkinson s Disease in the Older Patient David A. Hinkle, MD, PhD Comprehensive Movement Disorders Clinic Pittsburgh Institute for Neurodegenerative Diseases University of

More information

Insomnia Treatment in Brief

Insomnia Treatment in Brief Insomnia Treatment in Brief Project ECHO May 7, 2015 Jonathan Emens, M.D. Associate Professor, Departments of Psychiatry and Internal Medicine Oregon Health & Science University Staff Physician and Sleep

More information

Update on Pain: Collaborative Care for the Complex Patient

Update on Pain: Collaborative Care for the Complex Patient Update on Pain: Collaborative Care for the Complex Patient Nirmala R. Abraham, MD Medical Director Sycamore Pain Management Center Kettering Health Network Objectives Standardized approach to patient care

More information

Sleep & Wakefulness Disorders in Parkinson s Disease: The Challenge of Getting a Good Night s Sleep

Sleep & Wakefulness Disorders in Parkinson s Disease: The Challenge of Getting a Good Night s Sleep Sleep & Wakefulness Disorders in Parkinson s Disease: The Challenge of Getting a Good Night s Sleep Helene A. Emsellem, MD March 25, 2017 The Center for Sleep & Wake Disorders PFNCA Symposium Sleep is

More information

OUTLINE SLEEP UPDATE 2011 DISCLOSURES. David Claman, MD. Formerly on Lunesta Speakers Bureau Resigned 2011

OUTLINE SLEEP UPDATE 2011 DISCLOSURES. David Claman, MD. Formerly on Lunesta Speakers Bureau Resigned 2011 SLEEP UPDATE 2011 David Claman, MD Professor of Medicine UCSF Sleep Disorders Center DISCLOSURES Formerly on Lunesta Speakers Bureau Resigned 2011 Former Consultant for Provent Consulting activity was

More information

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York Program Highlights David Swope, MD Associate Professor of Neurology Mount Sinai Health System New York, New York Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone

More information

Parkinson s Founda.on

Parkinson s Founda.on Parkinson s Founda.on PD ExpertBriefing: Sleep and Parkinson s Led By: Aleksandar Videnovic, M.D., M.Sc. Associate Professor of Neurology; Director, MGH Program on Sleep, Circadian Biology and NeurodegeneraDon

More information

HEALTHY LIFESTYLE, HEALTHY SLEEP. There are many different sleep disorders, and almost all of them can be improved with lifestyle changes.

HEALTHY LIFESTYLE, HEALTHY SLEEP. There are many different sleep disorders, and almost all of them can be improved with lifestyle changes. HEALTHY LIFESTYLE, HEALTHY SLEEP There are many different sleep disorders, and almost all of them can be improved with lifestyle changes. HEALTHY LIFESTYLE, HEALTHY SLEEP There are many different sleep

More information

Sleep and Circadian Rhythm Disorders diagnosis and management

Sleep and Circadian Rhythm Disorders diagnosis and management Sleep and Circadian Rhythm Disorders diagnosis and management Dr Kirstie Anderson Consultant Neurologist Regional Sleep Service Newcastle www.neurone.org/sleep-resources Bedtime stories how to take a sleep

More information

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes. Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical

More information

LEGS SYNDROME RESTLESS D ETECTION MANAGEMENT. National Center on Sleep Disorders Research and Office of Prevention, Education, and Control AND

LEGS SYNDROME RESTLESS D ETECTION MANAGEMENT. National Center on Sleep Disorders Research and Office of Prevention, Education, and Control AND National Center on Sleep Disorders Research and Office of Prevention, Education, and Control RESTLESS LEGS SYNDROME D ETECTION AND MANAGEMENT IN PRIMARY CARE N A T I O N A L I N S T I T U T E S O F H E

More information

Management of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors*

Management of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors* Management of SSRI Induced Sexual Dysfunction John J. Miller, M.D. Medical Director, Center for Health and WellBeing Exeter, NH Serotonin Reuptake Inhibitors* fluoxetine clomipramine sertraline paroxetine

More information

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute Parkinson s Disease 2 nd most common neurodegenerative disorder Peak age at onset is 60 years

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. The synopsis

More information

Parkinson s disease: & related sleep disorders

Parkinson s disease: & related sleep disorders Parkinson s disease: & related sleep disorders PFNCA Symposium March 24 2018 Zahra N Rezvani MD, PhD University of Maryland I have no financial interest with any entity producing marketing, re-selling,

More information

Index. baclofen 73 basal forebrain nuclei 174

Index. baclofen 73 basal forebrain nuclei 174 Index acetazolamide 33 acetylcholine esterase inhibitor 174 actigraphy 14 activity meter 226 acute insomnia 4 α1 adrenergic activity 88 α 1 containing receptor 211 adenosine 108 advanced sleep phase syndrome

More information

Sleep Disorders. Hugh Selsick

Sleep Disorders. Hugh Selsick Sleep Disorders Hugh Selsick Obstructive Sleep Apnoea What it is: Repeated narrowing or collapse of the upper airway during sleep. Leads to choking, oxygen desaturations and repeated arousals. Physical

More information

Medications for the Treatment of Neuropathic Pain

Medications for the Treatment of Neuropathic Pain Medications for the Treatment of Neuropathic Pain February 23, 2011 Jinny Tavee, MD Associate Professor Neurological Institute Cleveland Clinic Foundation Neuropathic Pain Pain, paresthesias, and sensory

More information

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline 1. Pharmacist to order Narcotic Withdrawal Scores QH X 4 hours, then per table below: Narcotic Withdrawal Score

More information

Diana Corzine, MD ABMS Sleep Chief MT VA Sleep Medicine Common Sleep Disorders

Diana Corzine, MD ABMS Sleep Chief MT VA Sleep Medicine Common Sleep Disorders Diana Corzine, MD ABMS Sleep Chief MT VA Sleep Medicine 2018 Common Sleep Disorders Objectives: Understand Understand how Sleep Disorders affects health. Describe Describe some Common Sleep Disorders.

More information

노인병원에서 Light Therapy 의 활용 박 기 형 진주삼성병원 송도병원 신경과

노인병원에서 Light Therapy 의 활용 박 기 형 진주삼성병원 송도병원 신경과 Light Therapy 1 : 15 / 63 (23.8%) 1 : 7 2 : 8 : 6 / 86 (7%) 1, : 48 / 205 (23.4%) 1 : 43 2 : 5 Sleep in Geriatrics Prevalence NIH survey of 9000 american senior above age 65 ; 88% had sleep disturbances

More information

Modern Management of Sleep Disorders

Modern Management of Sleep Disorders Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance

More information

Pain Management Wrap-Up Chronic Care. David Tauben, MD Medicine Anesthesia & Pain Medicine

Pain Management Wrap-Up Chronic Care. David Tauben, MD Medicine Anesthesia & Pain Medicine Pain Management Wrap-Up Chronic Care David Tauben, MD Medicine Anesthesia & Pain Medicine Objectives Understand that Pain is Complex Know how to select Rx based on Pain type Be aware that Rx only reduces

More information

Restless Legs Syndrome

Restless Legs Syndrome CLINICAL REVIEW Restless Legs Syndrome Mathew M. Clark, MD Background: Restless legs syndrome is a common but not well-recognized central nervous system disorder that leads to insomnia and daytime distress.

More information

Overview. Sleep Related Movement Disorders - Restless Leg Syndrome - Periodic Limb movements in Sleep

Overview. Sleep Related Movement Disorders - Restless Leg Syndrome - Periodic Limb movements in Sleep The Structure of Sleep The Parasomnias - in REM - in Non-REM - Narcolepsy Overview Sleep Related Movement Disorders - Restless Leg Syndrome - Periodic Limb movements in Sleep Circadian Rhythm disorders

More information

Treating sleep disorders

Treating sleep disorders Treating sleep disorders Sue Wilson Centre for Neuropsychopharmacology Imperial College London sue.wilson@imperial.ac.uk Suggested algorithm for treatment of insomnia Diagnosis of insomnia Associated with

More information

14. Percent

14. Percent 4:30 5:45 pm Management of Insomnia and Other Disorders Presenter Disclosure Information The following relationships exist related to this presentation: Alon Y. Avidan, MD, MPH, FAAN, FAASM: Speakers Bureau

More information

Sleep Disorders in Women s Health

Sleep Disorders in Women s Health Sleep Disorders in Women s Health Diana Corzine, MD, ABMS Sleep Chief, Sleep Medicine Service Montana VA Health Care System Helena, Montana Understand which sleep disorders commonly impact women s Understand

More information

SLEEP DISORDERS. Kenneth C. Sassower, MD Division of Sleep Medicine; Department of Neurology Massachusetts General Hospital for Children

SLEEP DISORDERS. Kenneth C. Sassower, MD Division of Sleep Medicine; Department of Neurology Massachusetts General Hospital for Children SLEEP DISORDERS Kenneth C. Sassower, MD Division of Sleep Medicine; Department of Neurology Massachusetts General Hospital for Children Distinctive Features of Pediatric Sleep Daytime sleepiness uncommon

More information

Does oxycodone cause restless legs

Does oxycodone cause restless legs Does oxycodone cause restless legs 15-12-2015 Restless legs syndrome: Oxycodone/naloxone oxycodone /naloxone for restless legs syndrome should have their no apparent underlying cause. 8-11-2013 An oxycodone

More information

Modern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before

Modern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures If Only I Could Sleep Like I Did Before Sleep Case 52 yr. old WF with >4 yr. of poor sleep

More information

Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes

Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes Diabetes Ther (2018) 9:441 447 https://doi.org/10.1007/s13300-018-0376-6 EDITORIAL Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes Sanjay Kalra. Anu Gupta Received: January 22, 2018

More information

MISCELLANEOUS AGENTS - ALPHA-AGONISTS

MISCELLANEOUS AGENTS - ALPHA-AGONISTS Documentation A. FDA Approved Indications ADHD (Clonidine, Guanfacine) Documentation B. Non-FDA approved, commonly used psychiatric indications 1. Alcohol and opiate dependence 2. Opioid withdrawal 3.

More information

RESTLESS LEG SYNDROME: DETECTION AND MANAGEMENT IN PRIMARY CARE

RESTLESS LEG SYNDROME: DETECTION AND MANAGEMENT IN PRIMARY CARE RESTLESS LEG SYNDROME: DETECTION AND MANAGEMENT IN PRIMARY CARE By Marietta Farrell, RN, BSN The contents of this course are taken from the National Center on Sleep Disorders Research, National Institutes

More information

Restless Legs Syndrome: Associated Conditions. William Ondo, MD Methodist Neurological Institute

Restless Legs Syndrome: Associated Conditions. William Ondo, MD Methodist Neurological Institute Restless Legs Syndrome: Associated Conditions William Ondo, MD Methodist Neurological Institute Clinical Definition Urge to move the legs with or without paresthesias Symptoms worse during inactivity Symptoms

More information

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be

More information

Overview of Sleep Medicine

Overview of Sleep Medicine Overview of Sleep Medicine Rodney Smith. New York Times 11-18-2007 James E. Mojica, MD, FAASM Pulmonary, Sleep, Critical Care Massachusetts General Hospital Sleep Reversible state Perceptual disengagement

More information

The PD You Don t See: Cognitive and Non-motor Symptoms

The PD You Don t See: Cognitive and Non-motor Symptoms The PD You Don t See: Cognitive and Non-motor Symptoms Benzi M. Kluger, M.D., M.S. Assistant Professor of Neurology and Psychiatry University of Colorado Denver Goals 1) What are the most common non-motor

More information

Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome

Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome original article Comparison of with Pramipexole for Restless Legs Syndrome Richard P. Allen, Ph.D., Crystal Chen, M.D., Diego Garcia-Borreguero, M.D., Ph.D., Olli Polo, M.D., Sarah DuBrava, M.S., Jeffrey

More information

TOP 10 LIST OF SLEEP QUESTIONS. Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children

TOP 10 LIST OF SLEEP QUESTIONS. Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children TOP 10 LIST OF SLEEP QUESTIONS Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children QUESTION #1: ARE SLEEP ISSUES IN CHILDREN THE SAME AS IN ADULTS? Distinctive Features

More information

Annex I. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s)

Annex I. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) Annex I Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) Scientific conclusions Taking into account the PRAC Assessment Report on the PSUR(s) for ropinirole,

More information

Sleep disorders. Norbert Kozak

Sleep disorders. Norbert Kozak Sleep disorders Norbert Kozak About the sleep Each of us will spend about 1/3 of our lifetime sleeping....and 1/3 part of the population has sleep complain Sleep is an essential biological function, but

More information

Iron and The Restless Legs Syndrome

Iron and The Restless Legs Syndrome Iron and The Restless Legs Syndrome Erica R. Sun, Clara A. Chen, George Ho, Christopher J. Earley, and Richard P. Allen Johns Hopkins University Depts. of Psychology and Neurology, Dept. of Neurology at

More information

Disclosures. You're in Control or Urine Control Clinical Pearls of Drug Testing Case Studies. 9/20/17

Disclosures. You're in Control or Urine Control Clinical Pearls of Drug Testing Case Studies.   9/20/17 You're in Control or Urine Control Clinical Pearls of Drug Testing Case Studies Jeffrey Fudin, BS, PharmD, FCCP, FASHP www.paindr.com Disclosures Astra Zeneca (Speakers Bureau) Collegium (Consultant) Daiichi

More information

Sleep Disorders. Joel C. Marrs, Pharm.D., BCPS Clinical Assistant Professor. April 17, 2008

Sleep Disorders. Joel C. Marrs, Pharm.D., BCPS Clinical Assistant Professor. April 17, 2008 Sleep Disorders Joel C. Marrs, Pharm.D., BCPS Clinical Assistant Professor OSU/OHSU College of Pharmacy April 17, 2008 Learning Objectives Distinguish between the different categories of sleep disorders

More information

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology + Pharmacologic Treatment of Parkinson s Disease Nicholas J. Silvestri, M.D. Assistant Professor of Neurology + Overview n Brief review of Parkinson s disease (PD) n Clinical manifestations n Pathophysiology

More information

Modern Management of Sleep Disorders. Case. Introduction. Topics Covered. Douglas C. Bauer, MD University of California, San Francisco

Modern Management of Sleep Disorders. Case. Introduction. Topics Covered. Douglas C. Bauer, MD University of California, San Francisco Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance

More information

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology + Pharmacologic Treatment of Parkinson s Disease Nicholas J. Silvestri, M.D. Associate Professor of Neurology + Disclosures n NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT + Learning

More information

continuing education for pharmacists

continuing education for pharmacists continuing education for pharmacists Restless Legs Syndrome and Management Volume XXX, No. 2 Thomas A. Gossel, R.Ph., Ph.D., Professor Emeritus, Ohio Northern University, Ada, Ohio and J. Richard Wuest,

More information

Chronic Pain Pharmacist role in the clinic

Chronic Pain Pharmacist role in the clinic Chronic Pain Pharmacist role in the clinic WSPA Annual Meeting 2015 Alvin Goo, PharmD Clinical Associate Professor University of Washington Schools of Pharmacy and Family Medicine Speakers Declaration

More information